Biomedical and digital Health
We are committed to affordable and quality health care. Through efficient development of medicines and personalised lifestyle interventions. Find out more about our knowledge, tools and innovations.

Healthier people with biomedical and digital health
Healthcare costs are rising. We want to do something about it and we can. That is why we are relying on the latest technology, apps and data to make people healthier.
Our latest developments
Ex vivo organ perfusion provides accurate drug development data
TNO uses ex vivo normothermic organ perfusion to more accurately determine ADME processes for specific compounds and accelerate drug development.


Public Private Partnership supports intestinal health in early life
Public Private Partnership Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.


Webinar Personalised Health: From science to market
Are you interested in developing personalised health in order to contribute to a healthier society? Get inspired by the experience of companies that already innovate with us. Join our interactive webinar for the latest insights in personalised health: from science to market.
Personalised food conveniently delivered to your home
MixMasters develops, manufactures, and packages personalised health food and sports supplements. They try to bring healthy food to their customers in innovative ways and focus mainly on the sports and health industry.


TNO helps accelerate drug development through insight
To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.

